Nontuberculous mycobacterial infection after lung transplantation: a report of four cases

Surgical Case Reports

Table 1 Summary of 4 cases

Case No.	Age	Sex	Primary disease	Donar	Procedure	Period to onset^a (Month)	Organism	Infection lung	Symptom	Diagnosis	Drug	Period to negative conversion (month)	Treatment period (month)	Reinfection	outcome
1	10	M	PAH	Living	Bilateral	Late (76)	M.gordonae	Transplanted	None	BAL	None	5	–	None	Alive
2	35	F	BE	Living	Bilateral	Late (82)	MABSC	Transplanted	Fever Sputum	BAL	TAZ/PIPC+AZM	1	22	None	Alive
3	41	F	LAM	Cadaveric	Single	Late (58)	MABSC	Transplanted	Sputum	Sptum	AZM + IPM + AMK	4	12	None	Alive
4	39	M	NSIP	Cadaveric	Single	Early (12)	M.intracellurare	Native	Fever	Sptum	REC	3	21	None	Dead

AZM azithromycin, BAL broncho-alveolar lavage, BE bronchiectasis, CyA Cycrosporin, LAM lymphangioleiomyomatosis, M. Mycobacterium, MMF mycophenolate mofetil, NSIP nonspecific interstitial puemonia, PAH pulmonary arterial hypertension, PSL prednisolone, REC Rifampicin, ethambutol, and clarithromycin
^aEarly onset considered to occur within 180 days, late onset from 180 days until 3 years, and very late onset after 3 years